Enveric Biosciences, Inc. Common Stock (ENVB) is a publicly traded Healthcare sector company. As of October 21, 2026, ENVB trades at $1.55 with a market cap of $6.22M and a P/E ratio of -0.11. ENVB moved +0.00% today. Year to date, ENVB is -60.76%; over the trailing twelve months it is -83.17%. Its 52-week range spans $1.17 to $37.20. Rallies surfaces ENVB's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks hedge fund and 13F ownership for ENVB, including fund holders, share counts, and position changes when data is available.
| Metric | Value |
|---|---|
| Price | $1.55 |
| Market Cap | $6.22M |
| P/E Ratio | -0.11 |
| EPS | $-13.15 |
| Dividend Yield | 0.00% |
| 52-Week High | $37.20 |
| 52-Week Low | $1.17 |
| Volume | 56.76K |
| Avg Volume | 0 |
| Revenue (TTM) | $-571 |
| Net Income | $-8.73M |
| Gross Margin | 0.00% |
ENVB analyst coverage data. Average price target: $0.00.